Santarus (SNTS) Gets Mixed Ruling Over Generic Zegerid, Shares Halted
Tweet
Share
E-mailGet Alerts SNTS Hot Sheet
Join SI Premium – FREE
The trading halt in Santarus, Inc. (Nasdaq: SNTS) appears related to news of a mixed court ruling related to generic versions of Zegerid.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup set to join top banks in Anthropic IPO - Bloomberg
- 30-year mortgage rate dips to 6.65%, second weekly decline
- Invesco cuts fees 20% amid redemption backlog in real estate fund - Bloomberg
Create E-mail Alert Related Categories
FDA, Trader Talk, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
